MEDIA RELEASE
PARKWAY PANTAI EXPANDS HEALTHCARE OFFERINGS IN KEDAH THROUGH ACQUISITION OF AMANJAYA SPECIALIST CENTRE
Kuala Lumpur, 1 October 2018 – Parkway Pantai has acquired a 100 per cent stake in Amanjaya Specialist Centre Sdn Bhd. The deal enables Parkway Pantai to cater to patient volume growth at its wholly owned 118-bed Pantai Hospital Sungai Petani and expand its service offerings to the local community.
Joe Sim, Chief Executive Officer of Malaysia Operations Division, said, “Amanjaya Specialist Centre is a good fit with Parkway Pantai’s healthcare portfolio in Malaysia. The acquisition enables us to grow our healthcare services at Pantai Hospital Sungai Petani, which is operating at near maximum capacity. With the acquisition, Parkway Pantai will streamline and synergise the operations and services at Pantai Hospital Sungai Petani and Amanjaya Specialist Centre to better serve the patients in Kedah.”
Amanjaya Specialist Centre is a 98-bed multi-specialty hospital in Sungai Petani, Kedah. It is the first hospital in Malaysia to incorporate green technology and design in its construction and operations.
The acquisition will not affect clinical services at both hospitals. Patients will continue with their existing care plans at each facility until further notice.
In the months ahead, Amanjaya Specialist Centre will be renamed accordingly to fully leverage the brand name and 40-year hospital management expertise of Parkway Pantai.
Parkway Pantai operates 10 Pantai Hospitals and four Gleneagles Hospitals across Malaysia. Pantai Hospital Sungai Petani, acquired in 2009, is a 118-bed multidisciplinary specialist hospital offering a range of services including general medicine, general surgery, obstetrics and gynaecology, cardiology, ophthalmology and orthopaedics.
For more information, please contact:
Maygala Navaneetham Manager, Corporate Communications +60 12 6620 701 [email protected]
Sally Loh Assistant Manager, Corporate Communications +60 12 251 3326 [email protected]
- END -
About Parkway Pantai Parkway Pantai is one of Asia’s largest integrated private healthcare groups operating in Singapore, Malaysia, India, China, Brunei and United Arab Emirates. For over 40 years, its Mount Elizabeth, Gleneagles, Pantai and Parkway brands have established themselves as the region’s best known brands in private healthcare, synonymous with best-in-class patient experience and outcomes.
Leveraging its global track record for medical excellence and managing world-class hospitals, Parkway Pantai is committed to making a difference in people’s lives through excellent patient care, steadily expanding its reach in markets where demand for quality care is strong and growing. Parkway Pantai is a leading healthcare player in its home markets of Singapore, Malaysia and India and key growth markets of China and Hong Kong.
It is part of IHH Healthcare, one of the world’s largest healthcare group by market capitalisation. IHH operates more than 10,000 licensed beds across 49 hospitals in 9 countries worldwide, offering the full spectrum of integrated healthcare services from clinics to hospitals to quaternary care and a wide range of ancillary services including medical education.
For more information on Parkway Pantai, please visit www.parkwaypantai.com
About IHH Healthcare Berhad IHH Healthcare Berhad is a leading premium integrated healthcare provider in markets where the demand for quality care is strong and growing. We are one of the largest healthcare groups in the world by market capitalisation and are listed on the Main Market of Bursa Malaysia and the Main Board of SGX-ST.
Employing more than 35,000 people and operating over 10,000 licensed beds across 49 hospitals in 9 countries worldwide, the Group offers the full spectrum of integrated healthcare services from clinics to hospitals to quaternary care and a wide range of ancillary services across our three operating subsidiaries:
• Parkway Pantai Limited is one of Asia's largest integrated private healthcare groups with a network of 28 hospitals throughout the region, including Malaysia, Singapore, India, China, Brunei and UAE. Its “Mount Elizabeth”, “Gleneagles”, “Parkway” and “Pantai” brands are among the most prestigious in Asia. • Acibadem Holdings is Turkey’s leading private healthcare provider, offering integrated healthcare services across 21 hospitals in Turkey, Macedonia and Bulgaria. The “Acibadem” brand is renowned for its clinical excellence in the Central & Eastern Europe, Middle East and North Africa (“CEEMENA”) region. • IMU Health is IHH’s medical education arm, and oversees the established higher learning institutions of International Medical College (“IMC”) and International Medical University (“IMU”) in Malaysia.
IHH is the leading player in our home markets of Malaysia, Singapore, Turkey and India, and key growth markets of China and Hong Kong. For more information, please visit www.ihhhealthcare.com.